Invesco Pharmaceuticals ETF
PJP
96 hedge funds and large institutions have $101M invested in Invesco Pharmaceuticals ETF in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 26 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
24% more capital invested
Capital invested by funds: $81.2M → $101M (+$19.8M)
13% more funds holding
Funds holding: 85 → 96 (+11)
2.27% more ownership
Funds ownership: 14.91% → 17.18% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
+$5.58M |
| 2 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
+$4.64M |
| 3 |
Morgan Stanley
New York
|
+$1.88M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.72M |
| 5 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$865K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.47M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.4M |
| 3 |
Jane Street
New York
|
-$861K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$334K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$319K |
PJP Hedge Fund Activity: Q3 2018 in Review
96 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2018, worth a combined $101M — up 24% from $81.2M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PJP positions and 5 closed out — a net gain of 12 holders — while 22 added to existing stakes and 26 trimmed.
The largest buyer was Barometer Capital Management, opening a new position worth an estimated $5.58M. The largest seller was Citadel Advisors, cutting an estimated $1.47M.
- 96 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2018, up from 85 in Q2 2018.
- Funds reported $101M of Invesco Pharmaceuticals ETF stock for Q3 2018, up 24% quarter-over-quarter.
- 17 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2018 and 5 closed out, a net change of +12 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2018 was Barometer Capital Management, an estimated $5.58M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2018 was Citadel Advisors, an estimated $1.47M sold.
Based on aggregated 13F filings for Q3 2018.